Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 1.000 | strong | 0.989 | 88 | 4 | 1992 | 2020 | ||||||||
|
tet methylcytosine dioxygenase 2 | 0.458 | 0.808 | 4.3E-54 |
|
disease | 0.150 | None | 1.000 | 5 | 0 | 2010 | 2015 | ||||||||
|
serine and arginine rich splicing factor 2 | 0.561 | 0.731 | 0.48 |
|
disease | 0.120 | None | 1.000 | 2 | 0 | 2014 | 2015 | ||||||||
|
ASXL transcriptional regulator 1 | 0.482 | 0.808 | 1.3E-14 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
neurotrophic receptor tyrosine kinase 1 | 0.422 | 0.808 | 2.0E-06 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2001 | 2019 | ||||||||
|
platelet derived growth factor receptor alpha | 0.415 | 0.808 | 1.00 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2004 | 2018 | ||||||||
|
CD34 molecule | 0.368 | 0.808 | 5.0E-06 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2001 | 2020 | ||||||||
|
interferon stimulated exonuclease gene 20 | 0.414 | 0.846 | 2.9E-03 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2001 | 2014 | ||||||||
|
signal transducer and activator of transcription 5A | 0.445 | 0.808 | 1.00 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2008 | 2018 | ||||||||
|
TNF receptor superfamily member 8 | 0.444 | 0.808 | 0.86 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2011 | 2019 | ||||||||
|
signal transducer and activator of transcription 5B | 0.442 | 0.808 | 1.00 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2008 | 2018 | ||||||||
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2001 | 2014 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2013 | 2020 | ||||||||
|
interleukin 9 | 0.461 | 0.846 | 8.1E-07 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2002 | 2017 | ||||||||
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2013 | 2019 | ||||||||
|
nerve growth factor | 0.391 | 0.885 | 0.82 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2017 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
disease | 0.020 | None | 1.000 | 2 | 1 | 2010 | 2010 | ||||||||
|
tryptase delta 1 | 0.711 | 0.462 | 8.0E-12 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2007 | 2015 | ||||||||
|
immunoglobulin heavy constant epsilon | 0.626 | 0.538 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1995 | 2019 | |||||||||
|
interleukin 31 | 0.575 | 0.731 | 1.1E-02 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | ||||||||
|
factor interacting with PAPOLA and CPSF1 | 0.575 | 0.577 | 0.79 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2004 | 2006 | ||||||||
|
tryptase alpha/beta 1 | 0.722 | 0.500 | 1.3E-13 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
solute carrier family 16 member 1 | 0.499 | 0.846 | 7.4E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
tachykinin precursor 1 | 0.424 | 0.923 | 0.75 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 |